Cargando…
Variable Outcome of Immunotherapy in Advanced Multiple Cutaneous Squamous Cell Carcinomas in Two Patients with Recessive Dystrophic Epidermolysis Bullosa
Cutaneous squamous cell carcinoma (cSCC) is a major complication of recessive dystrophic epidermolysis bullosa (RDEB) that has high morbidity and mortality rates and unmet therapeutic needs. The aim of this study was to evaluate the molecular pattern of cSCC and the clinical course of immunotherapy...
Autores principales: | TREFZER, Laura, HESS, Maria E., SCHOLTEN, Lena, TECHNAU-HAFSI, Kristin, MEISS, Frank, BOERRIES, Melanie, HAS, Cristina, RAFEI-SHAMSABADI, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292046/ https://www.ncbi.nlm.nih.gov/pubmed/37338146 http://dx.doi.org/10.2340/actadv.v103.4870 |
Ejemplares similares
-
Case Report: Blurred Vision and Eruptive Nevi - Bilateral Diffuse Uveal Melanocytic Proliferation With Mucocutaneous Involvement in a Lung Cancer Patient
por: Rafei-Shamsabadi, David, et al.
Publicado: (2021) -
Dystrophic Epidermolysis Bullosa
por: Yadav, Randhir Sagar, et al.
Publicado: (2018) -
Reprogramming and Differentiation of Cutaneous Squamous Cell Carcinoma Cells in Recessive Dystrophic Epidermolysis Bullosa
por: Rami, Avina, et al.
Publicado: (2020) -
Quality of Life and Economic Burden in Recessive Dystrophic Epidermolysis Bullosa
por: Jeon, In Kyung, et al.
Publicado: (2016) -
Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa
por: Mack, Madison, et al.
Publicado: (2014)